Immediate Impact
19 standout
Citing Papers
Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity
2025 Standout
Targeting KRAS: from metabolic regulation to cancer treatment
2025 Standout
Works of Aditya Shreenivas being referenced
MEK-inhibitor (inh) and hydroxychloroquine (HCQ) in KRAS-mutated advanced pancreatic ductal adenocarcinoma (PDAC).
2022
Prognostic effect of specific RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC).
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Aditya Shreenivas | 213 | 188 | 60 | 64 | 45 | 319 | |
| Mukta Ramadwar | 159 | 150 | 124 | 57 | 44 | 370 | |
| Mahir Petkar | 153 | 132 | 48 | 43 | 42 | 308 | |
| Dan Ma | 181 | 198 | 35 | 99 | 23 | 339 | |
| Kikuo Sakamoto | 89 | 93 | 40 | 38 | 44 | 280 | |
| Danuta Skomra | 111 | 68 | 68 | 72 | 45 | 339 | |
| H Szpirglas | 99 | 98 | 37 | 62 | 35 | 321 | |
| Alfredo Matilla | 129 | 173 | 41 | 49 | 24 | 349 | |
| P Boccato | 136 | 196 | 23 | 84 | 27 | 332 | |
| Arzu Taşdemi̇r | 187 | 70 | 79 | 36 | 32 | 345 | |
| Rina Jiromaru | 190 | 189 | 56 | 30 | 32 | 337 |
All Works
Login with ORCID to disown or claim papers
Loading papers...